Identification of predictors of limited life expectancy in patients with asymptomatic abdominal aortic aneurysms
Description: Abdominal aortic aneurysm (AAA) has an increasing prevalence with age and AAA rupture is one of the leading causes of death in men over 65 years of age. To decrease the mortality from AAA, rupture can be prevented by elective aneurysm repair. The risk of AAA rupture increases with increasing diameter. Current treatment guidelines recommend that small and asymptomatic AAAs are observed as the risk of rupture is very low, while large aneurysms (=5.5 cm in men; =5 cm in women) should be treated surgically. Today, endovascular aneurysm repair (EVAR) is the preferred and less invasive alternative to open repair, especially in elderly patients with concomitant diseases. However, data is conflicting on whether frail patients should be treated with EVAR or not treated surgically at all, as a randomised controlled trial found no benefit for overall survival. The morbidity associated with elective AAA treatment must be weighed against the risk of rupture during the expected remaining life. In comorbid patients who are not suitable for open repair, this trade-off is difficult as patients may not live long enough to harvest the benefits of EVAR. Therefore, in frail patients, the threshold for indication for elective AAA repair might be at a larger diameter. A sliding scale for diameter, with lower hurdles for fitness as the aneurysm gets larger, is likely to be more appropriate for individual patients than a fixed threshold for diameter. Several studies have identified factors associated with poorer survival in patients with asymptomatic AAA. In 2018, Marques-Rios et al. identified 12 studies involving approximately 82'000 patients and investigated factors associated with long-term mortality after EVAR for asymptomatic AAA. Relatively consistent results were found for the association of older age, chronic kidney disease, chronic obstructive pulmonary disease, and heart failure with poorer long-term survival after EVAR. The aim of this research project is to improve the differentiation between patients with a favourable risk profile and those with limited life-expectancy by identification of predictors of limited life expectancy in patients with AAA. This research project will be conducted at the Vas¬cu¬lar Re¬search Unit of the Rigshospitalet in Copenhagen, Denmark. Denmark has a highly centralised health care system and aortic surgery is performed at only few centers. Health-related data are stored in different nationwide registries that contains basic patient information, information on diagnosis, treatment, laboratory parameters, prescription of medication, appointments, and survival information. Data on patients treated for AAA in the years 2010 to 2019 in Denmark will be retrieved from the Danish National Patient Register. Based on a renewed systematic literature review, a pre-selection of factors associated with survival in patients with AAA will be accomplished. Then, an automated variable selection process will be performed by regularisation using the least absolute shrinkage and selection operator technique in a semi-parametric Cox proportional hazard model. Thereafter, a predictive model for survival after AAA repair will be constructed and validated using resampling methods (i.e. bootstrapping).This research project can verify known and identify new predictors of limited life expectancy in a well-documented nationwide population. An overarching goal of this research project is to establish a risk score that will allow individualised treatment decisions to be made on a diameter scale depending on the presence of these predictors. This will help to establish an individualised monitoring programme and support continuous monitoring in frail patients with a short life expectancy, even if the diameter exceeds the current treatment threshold. In this way, the personal and socio-economic burden of unnecessary elective AAA treatments can be reduced. The observational retrospective nature of this research project inherently limits its value. However, findings of this research project might prompt further research in this field.
Amount: CHF 70,850
Funding type: fellowship
Funder scheme: Postdoc.Mobility
Start date: 2024-01-01
End date: 2024-12-31
Investigator: Meuli, Lorenz Christoph (lead)
Institution: Institution abroad
Subfield: Surgery
Field: Medicine
Domain: Health Sciences
Funded outputs count: 1
Funder award ID: 217674
OpenAlex ID: G7213113071
